Consenso mexicano en relación con la fracción exhalada de óxido nítrico (FeNO) en asma 2020

Autores/as

DOI:

https://doi.org/10.29262/ram.v67i0.760

Palabras clave:

Fracción exhalada de óxido nítrico, Asma, Corticosteroide inhalado, Adherencia terapéutica, Medicamento biológico, Dupilumab

Resumen

La fracción exhalada de óxido nítrico (FeNO) se relaciona con el nivel de inflamación eosinofílica en las vías aéreas y los niveles de interleucina-13, por lo que podría ser una herramienta diagnóstica y de seguimiento en el asma. Se convocó un grupo de trabajo integrado por neumólogos, expertos en fisiología de la respiración y alergólogos, con la finalidad de establecer criterios para el uso de la FeNO en asma en México. Mediante un método Delphi simplificado y discusión grupal, se consensaron varios puntos clave en relación con el uso de la FeNO. Sugerimos que la medición de la FeNO sirve para el diagnóstico de asma en clínicas especializadas, tanto en niños como adultos, así como para determinar el nivel de tratamiento con corticosteroides. En asma grave, recomendamos la FeNO para la endotipificación, detectar la mala adherencia terapéutica, el subtratamiento y el riesgo de crisis. Sugerimos su uso para determinar el nivel de tratamiento con corticosteroides e identificar pacientes con riesgo de tener una pérdida de la función pulmonar. También la recomendamos en el adulto para mejorar la elección de medicamentos biológicos y, en este contexto, solo la sugerimos en casos selectos en niños.

Citas

Global Burden of Disease Study 2016 (GBD 2016) data resources [En línea]. EE. UU.: Global Health Data Exchange; 2017. Disponible en: http://ghdx.healthdata.org/gbd-2016

Larenas-Linnemann D, Salas-Hernández J, Vázquez-García JC, Ortiz-Aldana I, Fernández-Vega M, Del Río-Navarro BE, et al. Mexican Asthma Guidelines: GUIMA 2017. Rev Alerg Mex. 2017;64(Suppl 1):s11-s128. DOI: 10.29262/ram.v64i0.272

Bai TR, Vonk JM, Postma DS, Boezen HM. Severe exacerbations predict excess lung function decline in asthma. Eur Respir J. 2007;30(3):452-456. DOI: 10.1183/09031936.00165106

Ortega H, Yancey SW, Keene ON, Gunsoy NB, Albers FC, Howarth PH. Asthma exacerbations associated with lung function decline in patients with severe eosinophilic asthma. J Allergy Clin Immunol Pract. 2018;6(3):980-986.e1. DOI: 10.1016/j.jaip.2017.12.019

Global Strategy for Asthma Management and Prevention. EE. UU.: Global Initiative for Asthma; 2020. Disponible en: https://ginasthma.org/reports/

Fajt ML, Wenzel SE. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. J Allergy Clin Immunol. 2015;135(2):299-310;quiz 311. DOI: 10.1016/j.jaci.2014.12.1871

Guía Española para el Manejo del Asma 4.4. España: Luzán 5; 2019. Disponible en: https://www.semg.es/images/documentos/GEMA_4_4.pdf

Godar M, Blanchetot C, de Haard H, Lambrecht BN, Brusselle G. Personalized medicine with biologics for severe type 2 asthma: current status and future prospects. MAbs. 2018;10(1):34-45. DOI: 10.1080/19420862.2017.1392425

Samitas K, Zervas E, Gaga M. T2-low asthma: current approach to diagnosis and therapy. Curr Opin Pulm Med. 2017;23(1):48-55. DOI: 10.1097/MCP.0000000000000342

Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, et al. After asthma: redefining airways diseases. Lancet. 2018;391(10118):350-400. DOI: 10.1016/S0140-6736(17)30879-6

Wagener AH, de Nijs SB, Lutter R, Sousa AR, Weersink EJ, Bel EH, et al. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma. Thorax. 2015;70(2):115-120. DOI: 10.1136/thoraxjnl-2014-205634

Westerhof GA, Korevaar DA, Amelink M, de Nijs SB, de Groot JC, Wang J, et al. Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes. Eur Respir J. 2015;46(3):688-696. DOI: 10.1183/09031936.00012415

Malinovschi A, Fonseca JA, Jacinto T, Alving K, Janson C. Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects. J Allergy Clin Immunol. 2013;132(4):821-827.e1-5. DOI: 10.1016/j.jaci.2013.06.007

Holguin F, Cardet JC, Chung KF, Diver S, Ferreira DS, Fitzpatrick A, et al. Management of severe asthma: a European Respiratory Society/American Thoracic Society Guideline. Eur Respir J. 2019. DOI: 10.1183/13993003.00588-2019

Soto-Ramos M, Gochicoa-Rangel L, Hinojos-Gallardo LC, Hernández-Saldaña R, Baquera-Arteaga M. Evaluación multidimensional del control en el paciente con asma. Aplicaciones clínicas en la toma de decisiones para el tratamiento. Neumol Cir Torax. 2013;72(1):52-61. Disponible en: https://www.medigraphic.com/pdfs/neumo/nt-2013/nt131i.pdf

Soto-Ramos M, Castro-Rodríguez JA, Hinojos-Gallardo LC, Hernández-Saldaña R, Cisneros-Castolo M, Carrillo-Rodríguez V. Fractional exhaled nitric oxide has a good correlation with asthma control and lung function in latino children with asthma. J Asthma. 2013;50(6):590-594. DOI: 10.3109/02770903.2013.792349

Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602-615. DOI: 10.1164/rccm.9120-11ST

Asthma: diagnosis, monitoring and chronic asthma management [En línea]. Reino Unido: National Institute for Health and Care Excellence; 2017. Disponible en: www.nice.org.uk/guidance/ng80

Petsky HL, Kew KM, Turner C, Chang AB. Exhaled nitric oxide levels to guide treatment for adults with asthma. Cochrane Database Syst Rev. 2016;9(9):CD011440. DOI: 10.1002/14651858.CD011440.pub2

Petsky HL, Kew KM, Chang AB. Exhaled nitric oxide levels to guide treatment for children with asthma. Cochrane Database Syst Rev. 2016;11(11):CD011439. DOI: 10.1002/14651858.CD011439.pub2

Essat M, Harnan S, Gomersall T, Tappenden P, Wong R, Pavord I, et al. Fractional exhaled nitric oxide for the management of asthma in adults: a systematic review. Eur Respir J. 2016;47(3):751-768. DOI: 10.1183/13993003.01882-2015

Lazarus SC, Krishnan JA, King TS, Lang JE, Blake KV, Covar R, et al. Mometasone or tiotropium in mild asthma with a low sputum eosinophil level. N Engl J Med. 2019;380(21):2009-2019. DOI: 10.1056/NEJMoa1814917

Price DB, Buhl R, Chan A, Freeman D, Gardener E, Godley C, et al. Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial. Lancet Respir Med. 2018;6(1):29-39. DOI: 10.1016/S2213-2600(17)30424-1

Woo SI, Lee JH, Kim H, Kang JW, Sun YH, Hahn YS. Utility of fractional exhaled nitric oxide (F(E)NO) measurements in diagnosing asthma. Respir Med. 2012;106(8):1103-9.

Sivan Y, Gadish T, Fireman E, Soferman R. The use of exhaled nitric oxide in the diagnosis of asthma in school children. J Pediatr. 2009;155(2):211-216. DOI: 10.1016/j.jpeds.2009.02.034

Malmberg LP, Pelkonen AS, Haahtela T, Turpeinen M. Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma. Thorax. 2003;58(6):494-499. DOI: 10.1136/thorax.58.6.494

Grzelewski T, Witkowski K, Makandjou-Ola E, Grzelewska A, Majak P, Jerzynska J, et al. Diagnostic value of lung function parameters and FeNO for asthma in schoolchildren in large, real-life population. Pediatr Pulmonol. 2014;49(7):632-640. DOI: 10.1002/ppul.22888

Martins C, Silva D, Severo M, Rufo J, Paciencia I, Madureira J, et al. Spirometry-adjusted fraction of exhaled nitric oxide increases accuracy for assessment of asthma control in children. Pediatr Allergy Immunol. 2017;28(8):754-762. DOI: 10.1111/pai.12803

Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath [En línea]. EE. UU.: National Institute for Health and Care Excellence; 2014. Disponible en: https://www.nice.org.uk/guidance/dg12

SIGN 158. British guideline on the management of asthma. A national clinical guideline. Reino Unido: British Thoracic Society/National Health Service Scotland; 2003. Disponible en: https://www.brit-thoracic.org.uk/document-library/guidelines/asthma/btssign-guideline-for-the-management-of-asthma-2019/

Pijnenburg MWH, de Jongste JC. Exhaled nitric oxide in childhood asthma: a review. Clin Exp Allergy. 2008;38(2):246-259. DOI: 10.1111/j.1365-2222.2007.02897.x.

Fleming L, Tsartsali L, Wilson N, Regamey N, Bush A. Longitudinal relationship between sputum eosinophils and exhaled nitric oxide in children with asthma. Am J Respir Crit Care Med. 2013;188(3):400-402. DOI: 10.1164/rccm.201212-2156LE

Pedroletti C, Lundahl J, Alving K, Hedlin G. Exhaled nitric oxide in asthmatic children and adolescents after nasal allergen challenge. Pediatr Allergy Immunol. 2005;16(1):59-64. DOI: 10.1111/j.1399-3038.2005.00200.x

Gaillard EA, McNamara PS, Murray CS, Pavord ID, Shields MD. Blood eosinophils as a marker of likely corticosteroid response in children with preschool wheeze: time for an eosinophil guided clinical trial? Clin Exp Allergy. 2015;45(9):1384-1395. DOI: 10.1111/cea.12535

Wandalsen GF, Solé D, Bacharier LB. Identification of infants and preschool children at risk for asthma: predictive scores and biomarkers. Curr Opin Allergy Clin Immunol. 2016;16(2):120-126. DOI: 10.1097/ACI.0000000000000240

Yao TC, Lee WI, Ou LS, Chen LC, Yeh KW, Huang JL, et al. Reference values of exhaled nitric oxide in healthy Asian children aged 5 to 18 years. Eur Respir J. 2012;39(2):378-384. DOI: 10.1183/09031936.00013911

Pijnenburg MW, Bakker EM, Hop WC, de Jongste JC. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med. 2005;172(7):831-836. DOI: 10.1164/rccm.200503-458OC

De Jongste JC, Carraro S, Hop WC, CHARISM Study Group, Baraldi E. Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma. Am J Respir Crit Care Med. 2009;179(2):93-97. DOI: 10.1164/rccm.200807-1010OC

Jartti T, Wendelin-Saarenhovi M, Heinonen I, Hartiala J, Vanto T. Childhood asthma management guided by repeated FeNO measurements: a meta-analysis. Paediatr Respir Rev. 2012;13(3):178-183. DOI: 10.1016/j.prrv.2011.11.002

Fritsch M, Uxa S, Horak F, Putschoegl B, Dehlink E, Szepfalusi Z, et al. Exhaled nitric oxide in the management of childhood asthma: a prospective 6-months study. Pediatr Pulmonol. 2006;41(9):855-862. DOI: 10.1002/ppul.20455

Lama M, Chatterjee M, Chaudhuri TK. Total serum immunoglobulin E in children with asthma. Indian J Clin Biochem. 2013;28(2):197-200. DOI: 10.1007/s12291-012-0247-2

Suresh V, Mih JD, George SC. Measurement of IL-13-induced iNOS-derived gas phase nitric oxide in human bronchial epithelial cells. Am J Respir Cell Mol Biol. 2007;37(1):97-104. DOI: 10.1165/rcmb.2006-0419OC

Schleich FN, Zanella D, Stefanuto PH, Bessonov K, Smolinska A, Dallinga JW, et al. Exhaled volatile organic compounds are able to discriminate between neutrophilic and eosinophilic asthma. Am J Respir Crit Care Med. 2019;200(4):444-453. DOI: 10.1164/rccm.201811-2210OC

Bradding P. Asthma: eosinophil disease, mast cell disease, or both? Allergy Asthma Clin Immunol. 2008;4(2):84-90. Disponible en: https://aacijournal.biomedcentral.com/articles/10.1186/1710-1492-4-2-84

Zeiger RS, Schatz M, Zhang F, Crawford WW, Kaplan MS, Roth RM, et al. Elevated exhaled nitric oxide is a clinical indicator of future uncontrolled asthma in asthmatic patients on inhaled corticosteroids. J Allergy Clin Immunol. 2011;128(2):412-414. DOI: 10.1016/j.jaci.2011.06.008

Matsunaga K, Hirano T, Oka A, Ito K, Edakuni N. Persistently high exhaled nitric oxide and loss of lung function in controlled asthma. Allergol Int. 2016;65(3):266-271. DOI: 10.1016/j.alit.2015.12.006

Price D, Ryan D, Burden A, von Ziegenweidt J, Gould S, Freeman D, et al. Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care. Clin Transl Allergy. 2013;3(1):37. Disponible en: https://ctajournal.biomedcentral.com/articles/10.1186/2045-7022-3-37

Hanania NA, Massanari M, Jain N. Measurement of fractional exhaled nitric oxide in real-world clinical practice alters asthma treatment decisions. Ann Allergy Asthma Immunol. 2018;120(4):414-418.e1. DOI: 10.1016/j.anai.2018.01.031

Hekking PP, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH. The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015;135(4):896-902. DOI: 10.1016/j.jaci.2014.08.042

Pavord ID, Afzalnia S, Menzies-Gow A, Heaney LG. The current and future role of biomarkers in type 2 cytokine-mediated asthma management. Clin Exp Allergy. 2017;47(2):148-160. DOI: 10.1111/cea.12881

Tice J, Walsh J, Synnott P, Kumar V, Adair E, Rind D, et al. Biologic therapies for treatment of asthma associated with type 2 inflammation: effectiveness, value, and value-based price benchmarks [En línea]. EE. UU.: Institute for Clinical and Economic Review; 2018. Disponible en: https://icer-review.org/wp-content/uploads/2018/04/ICER_Asthma_Draft_Report_092418v1.pdf

Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet. 2012;380(9842):651-659. DOI: 10.1016/S0140-6736(12)60988-X

Wenzel S, Castro M, Corren J, Maspero J, Wang L, Zhang B, et al. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting beta2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. Lancet. 2016;388(10039):31-44. DOI: 10.1016/S0140-6736(16)30307-5

Shrimanker R, Keene O, Hynes G, Wenzel S, Yancey S, Pavord ID. Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide and their combination in severe asthma: a post-hoc analysis. Am J Respir Crit Care Med. 2019;200(10):1308-1312. DOI: 10.1164/rccm.201903-0599LE

Hanania NA, Wenzel S, Rosen K, Hsieh HJ, Mosesova S, Choy DF, et al. Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study. Am J Respir Crit Care Med. 2013;187(8):804-811. DOI: 10.1164/rccm.201208-1414OC.

Busse WW. Are peripheral blood eosinophil counts a guideline for omalizumab treatment? STELLAIR says no! Eur Respir J. 2018;51(5):1800730; DOI: 10.1183/13993003.00730-2018

Attanasi M, Consilvio NP, Rapino D, Nicola MD, Scaparrotta A, Cingolani A, et al. Bronchial hyperresponsiveness to mannitol, airway inflammation and Asthma Control Test in atopic asthmatic children. Arch Med Sci. 2016;12(1):137-144. DOI: 10.5114/aoms.2016.57589

Karrasch S, Linde K, Rucker G, Sommer H, Karsch-Volk M, Kleijnen J, et al. Accuracy of FENO for diagnosing asthma: a systematic review. Thorax. 2017;72(2):109-116. DOI: 10.1136/thoraxjnl-2016-208704

Bannier MA, van de Kant KD, Jöbsis Q, Dompeling E. Biomarkers to predict asthma in wheezing preschool children. Clin Exp Allergy. 2015;45(6):1040-1050. DOI: 10.1111/cea.12460

Pijnenburg MW, Hofhuis W, Hop WC, de Jongste JC. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax. 2005;60(3):215-218. DOI: 10.1136/thx.2004.023374

Stern G, de Jongste J, van der Valk R, Baraldi E, Carraro S, Thamrin C, et al. Fluctuation phenotyping based on daily fraction of exhaled nitric oxide values in asthmatic children. J Allergy Clin Immunol. 2011;128(2):293-300. DOI: 10.1016/j.jaci.2011.03.010

Chang DV, Teper A, Balinotti J, Castro Simonelli C, Garcia-Bournissen F, Kofman C. Exhaled nitric oxide predicts loss of asthma control in children after inhaled corticosteroids withdrawal. Pediatr Pulmonol. 2019;54(5):537-543. DOI: 10.1002/ppul.24268

Petsky HL, Cates CJ, Kew KM, Chang AB. Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis. Thorax. 2018;73(12):1110-1119. DOI: 10.1136/thoraxjnl-2018-211540

Syk J, Malinovschi A, Johansson G, Unden AL, Andreasson A, Lekander M, et al. Anti-inflammatory treatment of atopic asthma guided by exhaled nitric oxide: a randomized, controlled trial. J Allergy Clin Immunol Pract. 2013;1(6):639-648.e1-8. DOI: 10.1016/j.jaip.2013.07.013

Yuan Y, Li B, Huang M, Peng X, Zhao W, Ye Y, et al. Fractional exhaled nitric oxide was not associated with the future risk of exacerbations in Chinese asthmatics: a non-interventional 1-year real-world study. J Thorac Dis. 2019;11(6):2438-2447. DOI: 10.21037/jtd.2019.05.47

Shrimanker R, Pavord I, Price R, Bradford E, Keene O, Yancey S. Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma. Am J Respir Crit Care Med. 2020;201:A5964. Disponible en: https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A5964

Bjerregaard A, Laing IA, Backer V, Sverrild A, Khoo SK, Chidlow G, et al. High fractional exhaled nitric oxide and sputum eosinophils are associated with an increased risk of future virus-induced exacerbations: a prospective cohort study. Clin Exp Allergy. 2017;47(8):1007-1013. DOI: 10.1111/cea.12935

Wang Z, Pianosi P, Keogh KA, Zaiem F, Alsawas M, Alahdab F, et al. The clinical utility of fractional exhaled nitric oxide (FeNO) in asthma management. Comparat Effectiveness Rev. 2017;197(18). DOI: 10.23970/AHRQEPCCER197.

Kuo CR, Spears M, Haughney J, Smith A, Miller J, Bradshaw T, et al. Scottish consensus statement on the role of FeNO in adult asthma. Respir Med. 2019;155:54-7. DOI: 10.1016/j.rmed.2019.07.010

Diagnosis and management of difficult-to-treat and severe asthma [En línea]. EE. UU.: Global Initiative for Asthma; 2019. Disponible en: https://ginasthma.org/severeasthma/

Nerpin E, Olivieri M, Gislason T, Olin AC, Nielsen R, Johannessen A, et al. Determinants of fractional exhaled nitric oxide in healthy men and women from the European Community Respiratory Health Survey III. Clin Exp Allergy. 2019;49(7):969-979.

Donnelly J, Cowan DC, Yeoman DJ, Lucas SJ, Herbison GP, Thomas KN, et al. Exhaled nitric oxide and pulmonary artery pressures during graded ascent to high altitude. Respiratory physiology & neurobiology. 2011;177(3):213-217. DOI: 10.1111/cea.13394

McDowell KM. Recent diagnosis techniques in pediatric asthma: impulse oscillometry in preschool asthma and use of exhaled nitric oxide. Immunol Allergy Clin North Am. 2019;39(2):205-219. DOI: 10.1016/j.iac.2018.12.002

Gabriele C, de Benedictis FM, de Jongste JC. Exhaled nitric oxide measurements in the first 2 years of life: methodological issues, clinical and epidemiological applications. Ital J Pediatr. 2009;35(1):21. DOI: 10.1186/1824-7288-35-21

Zhang J, Sun Y, Liu M, Sun C, Tian L. Predictive and diagnostic value of fractional exhaled nitric oxide in patients with chronic rhinosinusitis. Med Sci Monit. 2019;25:150-6. DOI: 10.12659/MSM.913295

Daniel PF, Klug B, Valerius NH. Exhaled nitric oxide in healthy young children during tidal breathing through a facemask. Pediatr Allergy Immunol. 2007;18(1):42-46. DOI: 10.1111/j.1399-3038.2006.00473.x

ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171(8):912-930. DOI: 10.1164/rccm.200406-710ST

Mattes Joerg, Storm-van’s Gravesande KS, Moeller C, Moseler M, Brandis M, Kuehr J. Circadian variation of exhaled nitric oxide and urinary eosinophil protein X in asthmatic and healthy children. Pediatr Res. 2002;51(2):190-194. DOI: 10.1203/00006450-200202000-00011

Gochicoa-Rangel L, Rojas-Cisneros F, Miguel-Reyes JL, Guerrero-Zuniga S, Mora-Romero U, Maldonado-Mortera AK, et al. Variability of FeNO in healthy subjects at 2240 meters above sea level. J Clin Monit Comput. 2015;30:445-449. DOI: 10.1007/s10877-015-9737-0

Antosova M, Bencova A, Psenkova A, Herle D, Rozborilova E. Exhaled nitric oxide - circadian variations in healthy subjects. Eur J Med Res. 2009;14(Suppl 4):6-8. DOI: 10.1186/2047-783X-14-S4-6

Hacken NH, van der Vaart H, van der Mark TW, Koëter GH, Postma DS. Exhaled nitric oxide is higher both at day and night in subjects with nocturnal asthma. Am J Respir Crit Care Med. 1998;158(3):902-907. DOI: 10.1164/ajrccm.158.3.9712021

Morris NH, Carroll S, Nicolaides KH, Steer PJ, Warren JB. Exhaled nitric oxide concentration and amniotic fluid nitrite concentration during pregnancy. Eur J Clin Invest. 1995;25(2):138-1341. DOI: 10.1111/j.1365-2362.1995.tb01539.x

Lipworth BJ, Jabbal S. Un-diagnosing persistent adult asthma. Eur Respir J. 2017;50(5):1701433. DOI: 10.1183/13993003.01433-2017

Clearie KL, McKinlay L, Williamson PA, Lipworth BJ. Fluticasone/salmeterol combination confers benefits in people with asthma who smoke. Chest. 2012;141(2):330-338. DOI: 10.1378/chest.11-0392

Silkoff PE, Wakita S, Chatkin J, Ansarin K, Gutierrez C, Caramori M, et al. Exhaled nitric oxide after b2-agonist inhalation and spirometry in asthma. Am J Respir Crit Care Med. 1999;159(3):940-944. DOI: 10.1164/ajrccm.159.3.9805044

Wong V, Lerner E. Nitric oxide inhibition strategies. Future Sci OA. 2015;1(1):FSO35. DOI: 10.4155/fso.15.35

Brozek GM, Jankowski M, Zejda JE. Acute respiratory responses to the use of e-cigarette: an intervention study. Sci Rep. 2019;9(1):6844. DOI: 10.1038/s41598-019-43324-1

Lappas AS, Tzortzi AS, Konstantinidi EM, Teloniatis SI, Tzavara CK, Gennimata SA, et al. Short-term respiratory effects of e-cigarettes in healthy individuals and smokers with asthma. Respirology. 2018;23(3):291-297. DOI: 10.1111/resp.13180

Marini S, Buonanno G, Stabile L, Ficco G. Short-term effects of electronic and tobacco cigarettes on exhaled nitric oxide. Toxicol Appl Pharmacol. 2014;278(1):9-15. DOI: 10.1016/j.taap.2014.04.004

Dressela H, de la Motte D, Reichert J, Ochmanna U, Petrua R, Angerera P, et al. Exhaled nitric oxide: independent effects of atopy, smoking, respiratory tract infection, gender and height. Respir Med. 2008;102(7):962-969. DOI: 10.1016/j.rmed.2008.02.012

Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med. 2000;162(6):2341-2351. DOI: 10.1164/ajrccm.162.6.ats9-00

Arnold RJ, Massanari M, Lee TA, Brooks E. A review of the utility and cost effectiveness of monitoring fractional exhaled nitric oxide (FeNO) in asthma management. Manag Care. 2018;27(7):34-41. Disponible en: https://www.managedcaremag.com/linkout/2018/7/34

Brooks EA, Massanari M. Cost-effectiveness analysis of monitoring fractional exhaled nitric oxide (FeNO) in the management of asthma. Manag Care. 2018;27(7):42-48. Disponible en: https://www.managedcaremag.com/linkout/2018/7/42

Brooks EA, Massanari M, Hanania NA, Weiner DJ. Cost-effectiveness of fractional exhaled nitric oxide (FeNO) measurement in predicting response to omalizumab in asthma. Clinicoecon Outcomes Res. 2019;11:301-307. DOI: 10.2147/CEOR.S177207

Sabatelli L, Seppälä U, Sastre J, Crater G. Cost-effectiveness and budget impact of routine use of fractional exhaled nitric oxide monitoring for the management of adult asthma patients in Spain. J Investig Allergol Clin Immunol. 2017;27(2):89-97. DOI: 10.18176/jiaci.0103

Bakirtas A. Diagnostic challenges of childhood asthma. Curr Opin Pulm Med. 2017;23(1):27-33. DOI: 10.1097/MCP.0000000000000338

Avital A, Uwyyed K, Berkman N, Godfrey S, Bar-Yishay E, Springer C. Exhaled nitric oxide and asthma in young children. Pediatr Pulmonol. 2001;32(4):308-313. DOI: 10.1002/ppul.1124 95.

Buchvald F, Baraldi E, Carraro S, Gaston B, de Jongste JD, Pijnenburg MWH, et al. Measurementes of exhaled nitric oxide in healty subjects age 4 to 17. J Allergy Clin Immunol. 2005;115(6):1130-1136. DOI: 10.1016/j.jaci.2005.03.020

Gabriele C, Nieuwhof EM, van der Wiel EC, Hofhuis W, Moll HA, Merkus PJ, et al. Exhaled nitric oxide differentiates airway diseases in the first two years of life. Pediatr Res. 2006;60(4):461-465. DOI: 10.1203/01.pdr.0000238242.39881.64

Wildhaber JH, Hall GL, Stick SM. Measurements of exhaled nitric oxide with the single-breath technique and positive expiratory pressure in infants. Am J Respir Crit Care Med. 1999;159(1):74-78. DOI: 10.1164/ajrccm.159.1.9805021

Meyts I, Proesmans M, van Gerven V, Hoppenbrouwers K, de Boeck K. Tidal off-line exhaled nitric oxide measurements in a pre-school population. Eur J Pediatr. 2003;162(7-8):506-510. DOI: 10.1007/s00431-003-1215-x

van der Heijden HH, Brouwer ML, Hoekstra F, van der Pol P, Merkus PJ. Reference values of exhaled nitric oxide in healthy children 1-5 years using off-line tidal breathing. Pediatr Pulmonol. 2014;49(3):291-295. DOI: 10.1002/ppul.22796. Epub 2013 Mar 26

Descargas

Publicado

2020-10-05